These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12393458)

  • 21. Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.
    Persaud K; Tille JC; Liu M; Zhu Z; Jimenez X; Pereira DS; Miao HQ; Brennan LA; Witte L; Pepper MS; Pytowski B
    J Cell Sci; 2004 Jun; 117(Pt 13):2745-56. PubMed ID: 15150322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.
    Lee YJ; Karl DL; Maduekwe UN; Rothrock C; Ryeom S; D'Amore PA; Yoon SS
    Cancer Res; 2010 Nov; 70(21):8357-67. PubMed ID: 20978198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
    Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
    J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
    Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
    Dunk C; Ahmed A
    Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.
    Nakao S; Zandi S; Hata Y; Kawahara S; Arita R; Schering A; Sun D; Melhorn MI; Ito Y; Lara-Castillo N; Ishibashi T; Hafezi-Moghadam A
    Blood; 2011 Jan; 117(3):1081-90. PubMed ID: 20705758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.
    Zhao B; Smith G; Cai J; Ma A; Boulton M
    Br J Ophthalmol; 2007 Apr; 91(4):538-45. PubMed ID: 16943230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.
    Foster RR; Slater SC; Seckley J; Kerjaschki D; Bates DO; Mathieson PW; Satchell SC
    Am J Pathol; 2008 Oct; 173(4):938-48. PubMed ID: 18772335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.
    Fitzpatrick TE; Lash GE; Yanaihara A; Charnock-Jones DS; Macdonald-Goodfellow SK; Graham CH
    Exp Cell Res; 2003 Feb; 283(2):247-55. PubMed ID: 12581744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
    Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
    Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
    Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
    Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
    Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
    Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.
    Kubo H; Fujiwara T; Jussila L; Hashi H; Ogawa M; Shimizu K; Awane M; Sakai Y; Takabayashi A; Alitalo K; Yamaoka Y; Nishikawa SI
    Blood; 2000 Jul; 96(2):546-53. PubMed ID: 10887117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.
    Nie L; Guo X; Esmailzadeh L; Zhang J; Asadi A; Collinge M; Li X; Kim JD; Woolls M; Jin SW; Dubrac A; Eichmann A; Simons M; Bender JR; Sadeghi MM
    J Clin Invest; 2013 Dec; 123(12):5082-97. PubMed ID: 24177422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.